Henry Schein, Inc. $HSIC Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard Group trimmed its position in Henry Schein by 3.4% in Q4, selling 412,577 shares and leaving it with 11,588,199 shares (about 9.84%), valued at $875.8 million.
• Company insiders sold 105,911 shares worth $8.57 million in the last three months — including CEO Stanley Bergman (43,812 shares) and EVP Mark Mlotek (5,925 shares) — leaving insiders with 0.89% ownership.
• Analysts are mixed but the consensus rating is a "Hold" with an average price target of $87.75 (6 Buys, 7 Holds, 1 Sell); the company also issued FY2026 EPS guidance of 5.230–5.370 and the stock recently traded near $73.93.

Vanguard Group Inc. lowered its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,588,199 shares of the company's stock after selling 412,577 shares during the period. Vanguard Group Inc. owned about 9.84% of Henry Schein worth $875,836,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of HSIC. Ameriprise Financial Inc. lifted its position in shares of Henry Schein by 3,275.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company's stock valued at $165,594,000 after acquiring an additional 2,199,695 shares during the period. Bank of America Corp DE lifted its position in shares of Henry Schein by 204.2% during the 2nd quarter. Bank of America Corp DE now owns 995,375 shares of the company's stock valued at $72,712,000 after acquiring an additional 668,182 shares during the period. SG Americas Securities LLC lifted its position in shares of Henry Schein by 171.9% during the 4th quarter. SG Americas Securities LLC now owns 820,698 shares of the company's stock valued at $62,028,000 after acquiring an additional 518,914 shares during the period. Artisan Partners Limited Partnership lifted its position in shares of Henry Schein by 5.7% during the 3rd quarter. Artisan Partners Limited Partnership now owns 6,833,041 shares of the company's stock valued at $453,509,000 after acquiring an additional 370,837 shares during the period. Finally, Tudor Investment Corp ET AL acquired a new stake in shares of Henry Schein during the 3rd quarter valued at approximately $15,375,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of research reports. Morgan Stanley reiterated an "underweight" rating and set a $64.00 price target (up from $61.00) on shares of Henry Schein in a research report on Friday, April 24th. Leerink Partners reiterated a "market perform" rating on shares of Henry Schein in a research report on Monday, March 9th. Citigroup initiated coverage on shares of Henry Schein in a research report on Wednesday, April 15th. They set a "buy" rating and a $100.00 price target for the company. Barrington Research set a $97.00 price target on shares of Henry Schein and gave the company an "outperform" rating in a research report on Wednesday, February 25th. Finally, BTIG Research initiated coverage on shares of Henry Schein in a research report on Thursday, April 16th. They set a "neutral" rating for the company. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $87.75.

Henry Schein Trading Down 0.9%

Shares of Henry Schein stock opened at $73.93 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.38 and a quick ratio of 0.76. Henry Schein, Inc. has a 1 year low of $61.94 and a 1 year high of $89.29. The company has a market capitalization of $8.48 billion, a P/E ratio of 22.61, a P/E/G ratio of 2.19 and a beta of 0.82. The business has a 50 day moving average price of $76.59 and a 200 day moving average price of $74.77.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.04. Henry Schein had a return on equity of 15.16% and a net margin of 3.02%.The firm had revenue of $3.44 billion during the quarter, compared to the consensus estimate of $3.34 billion. During the same period in the previous year, the firm posted $1.19 EPS. The company's quarterly revenue was up 7.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 5.3 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, EVP Mark E. Mlotek sold 5,925 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $80.80, for a total value of $478,740.00. Following the completion of the sale, the executive vice president directly owned 80,554 shares of the company's stock, valued at approximately $6,508,763.20. The trade was a 6.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stanley M. Bergman sold 43,812 shares of Henry Schein stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $81.31, for a total transaction of $3,562,353.72. Following the completion of the sale, the chief executive officer directly owned 383,803 shares of the company's stock, valued at $31,207,021.93. The trade was a 10.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 105,911 shares of company stock worth $8,574,982 in the last three months. 0.89% of the stock is currently owned by company insiders.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.